Insider Selling: Paragon 28, Inc. (NYSE:FNA) Major Shareholder Sells 619,747 Shares of Stock

Paragon 28, Inc. (NYSE:FNA - Get Free Report) major shareholder Mvm Partners, Llc sold 619,747 shares of Paragon 28 stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $12.99, for a total transaction of $8,050,513.53. Following the sale, the insider now directly owns 9,609,771 shares of the company's stock, valued at $124,830,925.29. This represents a 6.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Thursday, March 6th, Mvm Partners, Llc sold 164,664 shares of Paragon 28 stock. The stock was sold at an average price of $13.01, for a total value of $2,142,278.64.
• On Monday, January 27th, Mvm Partners, Llc sold 27,142 shares of Paragon 28 stock. The shares were sold at an average price of $11.62, for a total value of $315,390.04.
• On Thursday, January 23rd, Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock. The stock was sold at an average price of $11.63, for a total value of $234,181.68.

Paragon 28 Price Performance

FNA traded down $0.02 on Monday, hitting $13.02. 943,326 shares of the company's stock were exchanged, compared to its average volume of 838,079. Paragon 28, Inc. has a fifty-two week low of $4.65 and a fifty-two week high of $13.13. The stock has a market cap of $1.09 billion, a price-to-earnings ratio of -17.59 and a beta of 1.54. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The firm has a 50-day moving average price of $12.07 and a 200-day moving average price of $9.35.

Remove Ads

Wall Street Analysts Forecast Growth

FNA has been the topic of several analyst reports. Canaccord Genuity Group set a $13.00 price target on shares of Paragon 28 in a report on Wednesday, January 29th. Needham & Company LLC restated a "hold" rating and issued a $13.00 target price on shares of Paragon 28 in a report on Wednesday, January 29th. Stephens reaffirmed an "equal weight" rating and set a $13.00 price objective (down from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Finally, William Blair lowered Paragon 28 from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $14.20.

Hedge Funds Weigh In On Paragon 28

Several large investors have recently made changes to their positions in the stock. Venturi Wealth Management LLC purchased a new position in Paragon 28 in the fourth quarter valued at $36,000. AlphaQuest LLC raised its stake in Paragon 28 by 33.6% during the 4th quarter. AlphaQuest LLC now owns 3,680 shares of the company's stock worth $38,000 after acquiring an additional 925 shares in the last quarter. State of Wyoming lifted its holdings in shares of Paragon 28 by 37.4% in the 4th quarter. State of Wyoming now owns 4,359 shares of the company's stock valued at $45,000 after purchasing an additional 1,187 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Paragon 28 in the fourth quarter valued at approximately $94,000. Finally, Intech Investment Management LLC acquired a new position in Paragon 28 in the third quarter valued at $70,000. 63.57% of the stock is currently owned by institutional investors and hedge funds.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.